机译:多发性骨髓瘤同种异体造血干细胞移植后存活时间延长的预测因素? sup>
Department of Stem Cell Transplantation and Cellular Therapy The University of Texas MD Anderson Cancer Center Houston Texas;
Department of Public Health and Primary Care Strangeways Research Laboratory Cambridge United Kingdom;
Department of Lymphoma/Myeloma The University of Texas MD Anderson Cancer Center Houston Texas;
Department of Internal Medicine University of Pittsburgh Pittsburgh Pennsylvania;
Department of Biostatistics The University of Texas MD Anderson Cancer Center Houston Texas;
Department of Blood and Marrow Transplantation Memorial Sloan Kettering Cancer Center New York New York;
机译:多发性骨髓瘤同种异体造血干细胞移植后存活时间延长的预测因子
机译:造血细胞移植合并症指数可预测多发性骨髓瘤自体造血细胞移植后的存活率
机译:基因异常对多发性骨髓瘤同种异体造血干细胞移植后存活的影响
机译:循环肿瘤DNA预测AML和MDS中的同种异体造血干细胞移植
机译:接受同种异体造血干细胞移植的患者的供体选择:加拿大造血干细胞移植医生的优先事项评估。
机译:同种异体造血干细胞移植治疗多发性骨髓瘤后长时间存活的预测
机译:通过美法仑/全身照射条件的清髓性同种异体造血细胞移植之前的原发性浆细胞白血病和难治性多发性多发性骨髓瘤伴有疾病的患者可以延长生存时间